Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

NPD4928 is an inhibitor of ferroptosis suppressor protein 1 (FSP1) and an enhancer of ferroptosis.1 It binds to FSP1 and inhibits its activity in a cell-free NADH consumption assay. NPD4928 (3 µM) enhances cytotoxicity induced by the ferroptosis inducer RSL3 (Item No. 19288) in PANC-1 prostate cancer cells in a synergistic manner. It also enhances cytotoxicity induced by sulfasalazine (Item No. 15025) and L-buthionine sulfoximine (BSO) in the same cells. NPD4928 in combination with RSL3 induces cytotoxicity in PC3, MKN74, DU145, MIA PaCa-2, and A549 cancer cells (IC50s = 105, 95, 103, 140, and 155 nM, respectively) but not BxPC-3 or RPMI-8226 cancer cells (IC50s = >30 µM for both).
WARNING This product is not for human or veterinary use.
1. Identification of a small molecule that enhances ferroptosis via inhibition of ferroptosis suppressor protein 1 (FSP1). ACS Chem Biol. 17(2), 483-491 (2022).